Related Experiment Video
Updated: Oct 2, 2026

Using Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells for Drug Discovery
Published on: May 19, 2018
Personalized drug discovery from rare diseases to cancer
1Translational Oncology Research Center, Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Doha, Qatar. vkatanaev@hbku.edu.qa.
Abstract:
Precision medicine selects individual treatments from a small toolbox of therapies already available. Personalized drug discovery (PDD) brings this concept one step ahead, developing drugs for individual patient's diseases. Currently, PDD is being developed for rare disorders, where conventional drug discovery paradigms are non-applicable due to small patient sizes, but also for cancer. As a new frontier in precision medicine, PDD should be upscaled in rare and non-rare diseases.
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenomics: Identification of New Drug Targets
Drug Discovery: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
